SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-21-187793
Filing Date
2021-06-10
Accepted
2021-06-10 16:13:01
Documents
4
Group Members
CANAAN PARTNERS XI LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d190680dsc13d.htm SC 13D 65490
2 EX-24 d190680dex24.htm EX-24 13284
3 EX-99.1 d190680dex991.htm EX-99.1 4105
4 EX-99.3 d190680dex993.htm EX-99.3 31173
  Complete submission text file 0001193125-21-187793.txt   115730
Mailing Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880 203-855-0400
Canaan XI L.P. (Filed by) CIK: 0001712417 (see all company filings)

IRS No.: 981377917 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Subject) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92582 | Film No.: 211008204
SIC: 2834 Pharmaceutical Preparations